Skip to main content
. Author manuscript; available in PMC: 2013 Apr 23.
Published in final edited form as: AIDS Care. 2011 May;23(5):569–577. doi: 10.1080/09540121.2010.525607

Table 2.

Frequencies of different types of treatment switches

% (n) of subjects with treatment switch (n=59)* % (n) of treatment switches (n=74)
d4T to AZT 42 (25) 34 (25)
AZT to d4T 14 (8) 11 (8)
NVP to EFV 7 (4) 5 (4)
EFV to NVP 10 (6) 8 (6)
1st to 2nd line therapy 12 (7) 10 (7)
Other switches 31 (18) 32 (24)

d4T: Stavudine, AZT: Zidovudine, NVP: Nevirapine, EFV: Efavirenz

*

Percentages do not add up to 100 %, because some subjects had multiple switches.